Report Detail

Pharma & Healthcare Global Ponatinib Market Professional Survey Report 2019

  • RnM3792442
  • |
  • 30 September, 2019
  • |
  • Global
  • |
  • 106 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Ponatinib Drugs is an oral drug developed by ARIAD Pharmaceuticalsfor the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia(ALL).

The global Ponatinib market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ponatinib volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ponatinib market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ponatinib in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ponatinib manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
ARIAD Pharmaceuticals
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
45mg
15mg

Segment by Application
CML
ALL


Table of Contents

    Executive Summary

      1 Industry Overview of Ponatinib

      • 1.1 Definition of Ponatinib
      • 1.2 Ponatinib Segment by Type
        • 1.2.1 Global Ponatinib Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 45mg
        • 1.2.3 15mg
      • 1.3 Ponatinib Segment by Applications
        • 1.3.1 Global Ponatinib Consumption Comparison by Applications (2014-2025)
        • 1.3.2 CML
        • 1.3.3 ALL
      • 1.4 Global Ponatinib Overall Market
        • 1.4.1 Global Ponatinib Revenue (2014-2025)
        • 1.4.2 Global Ponatinib Production (2014-2025)
        • 1.4.3 North America Ponatinib Status and Prospect (2014-2025)
        • 1.4.4 Europe Ponatinib Status and Prospect (2014-2025)
        • 1.4.5 China Ponatinib Status and Prospect (2014-2025)
        • 1.4.6 Japan Ponatinib Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Ponatinib Status and Prospect (2014-2025)
        • 1.4.8 India Ponatinib Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Ponatinib
      • 2.3 Manufacturing Process Analysis of Ponatinib
      • 2.4 Industry Chain Structure of Ponatinib

      3 Development and Manufacturing Plants Analysis of Ponatinib

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Ponatinib Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Ponatinib
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Ponatinib Production and Capacity Analysis
      • 4.2 Ponatinib Revenue Analysis
      • 4.3 Ponatinib Price Analysis
      • 4.4 Market Concentration Degree

      5 Ponatinib Regional Market Analysis

      • 5.1 Ponatinib Production by Regions
        • 5.1.1 Global Ponatinib Production by Regions
        • 5.1.2 Global Ponatinib Revenue by Regions
      • 5.2 Ponatinib Consumption by Regions
      • 5.3 North America Ponatinib Market Analysis
        • 5.3.1 North America Ponatinib Production
        • 5.3.2 North America Ponatinib Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Ponatinib Import and Export
      • 5.4 Europe Ponatinib Market Analysis
        • 5.4.1 Europe Ponatinib Production
        • 5.4.2 Europe Ponatinib Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Ponatinib Import and Export
      • 5.5 China Ponatinib Market Analysis
        • 5.5.1 China Ponatinib Production
        • 5.5.2 China Ponatinib Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Ponatinib Import and Export
      • 5.6 Japan Ponatinib Market Analysis
        • 5.6.1 Japan Ponatinib Production
        • 5.6.2 Japan Ponatinib Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Ponatinib Import and Export
      • 5.7 Southeast Asia Ponatinib Market Analysis
        • 5.7.1 Southeast Asia Ponatinib Production
        • 5.7.2 Southeast Asia Ponatinib Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Ponatinib Import and Export
      • 5.8 India Ponatinib Market Analysis
        • 5.8.1 India Ponatinib Production
        • 5.8.2 India Ponatinib Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Ponatinib Import and Export

      6 Ponatinib Segment Market Analysis (by Type)

      • 6.1 Global Ponatinib Production by Type
      • 6.2 Global Ponatinib Revenue by Type
      • 6.3 Ponatinib Price by Type

      7 Ponatinib Segment Market Analysis (by Application)

      • 7.1 Global Ponatinib Consumption by Application
      • 7.2 Global Ponatinib Consumption Market Share by Application (2014-2019)

      8 Ponatinib Major Manufacturers Analysis

      • 8.1 ARIAD Pharmaceuticals
        • 8.1.1 ARIAD Pharmaceuticals Ponatinib Production Sites and Area Served
        • 8.1.2 ARIAD Pharmaceuticals Product Introduction, Application and Specification
        • 8.1.3 ARIAD Pharmaceuticals Ponatinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served

      9 Development Trend of Analysis of Ponatinib Market

      • 9.1 Global Ponatinib Market Trend Analysis
        • 9.1.1 Global Ponatinib Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Ponatinib Regional Market Trend
        • 9.2.1 North America Ponatinib Forecast 2019-2025
        • 9.2.2 Europe Ponatinib Forecast 2019-2025
        • 9.2.3 China Ponatinib Forecast 2019-2025
        • 9.2.4 Japan Ponatinib Forecast 2019-2025
        • 9.2.5 Southeast Asia Ponatinib Forecast 2019-2025
        • 9.2.6 India Ponatinib Forecast 2019-2025
      • 9.3 Ponatinib Market Trend (Product Type)
      • 9.4 Ponatinib Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Ponatinib Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Ponatinib. Industry analysis & Market Report on Ponatinib is a syndicated market report, published as Global Ponatinib Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Ponatinib market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,782.50
        4,173.75
        5,565.00
        3,237.50
        4,856.25
        6,475.00
        547,470.00
        821,205.00
        1,094,940.00
        292,355.00
        438,532.50
        584,710.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report